Mycobacterium tuberculosislipomannan blocks TNF biosynthesis by regulating macrophage MAPK-activated protein kinase 2 (MK2) and microRNA miR-125b

Abstract

Contact of Mycobacterium tuberculosis (M.tb) with the immune system requires interactions between microbial surface molecules and host pattern recognition receptors. Major M.tb-exposed cell envelope molecules, such as lipomannan (LM), contain subtle structural variations that affect the nature of the immune response. Here we show that LM from virulent M.tb (TB-LM), but not from avirulent Myocobacterium smegmatis (SmegLM), is a potent inhibitor of TNF biosynthesis in human macrophages. This difference in response is not because of variation in Toll-like receptor 2-dependent activation of the signaling kinase MAPK p38. Rather, TB-LM stimulation leads to destabilization of TNF mRNA transcripts and subsequent failure to produce TNF protein. In contrast, SmegLM enhances MAPKactivated protein kinase 2 phosphorylation, which is critical for maintaining TNF mRNA stability in part by contributing microRNAs (miRNAs). In this context, human miRNA miR-125b binds to the 3′ UTR region of TNF mRNA and destabilizes the transcript, whereas miR-155 enhances TNF production by increasing TNF mRNA half-life and limiting expression of SHIP1, a negative regulator of the PI3K/ Akt pathway. We show that macrophages incubated with TB-LM and live M.tb induce high miR-125b expression and low miR-155 expression with correspondingly low TNF production. In contrast, SmegLM and live M. smegmatis induce high miR-155 expression and low miR-125b expression with high TNF production. Thus, we identify a unique cellular mechanism underlying the ability of a major M.tb cell wall component, TB-LM, to block TNF biosynthesis in human macrophages, thereby allowing M.tb to subvert host immunity and potentially increase its virulence.lipoglycans | innate immunity | cell signaling | intracellular pathogen

Comprehensive identification and profiling of Nile tilapia (Oreochromis niloticus) microRNAs response to Streptococcus agalactiae infection through high-throughput sequencing

“…For example, mir-125 is downregulated in response to LPS or bacterial pathogens and one target of mir-125 is TNF-a. In macrophages, an additional function of mir-125 may be to ensure that the TLR pathway is turned off in the absence of microbial infection, while its downregulation in response to TLR triggering may be needed for the inflammatory response [48]. In this study, we also identified mir-125 in tilapia, which shared 100% sequence with other three kinds of fish.…”

Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies

“…[146][147] There is emerging evidence that miRNAs could serve as cancer immunotherapy and could serve as therapeutic targets in TB. [148][149] Cytokines and proteases TNF-α is essential to granuloma integrity, macrophage antimicrobial activity and ROSmediated Mtb killing.…”

MiR-125 in normal and malignant hematopoiesis

“…MiR-125b acts as a negative regulator of this pathway by reducing the levels of its target tumor necrosis factora 15,34 and, unusual for miRNAs, by enhancing the stability of the NF-kb inhibitor NKIRAS2 (KBRAS2) 35 ( Figure 3). Enhancement of the stability of a target gene transcript was described in several recent publications.…”